Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Nanotechnology could improve scar treatment but needs more development.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Tribulus terrestris may protect the liver from drug damage.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

TRPV1 affects sebaceous gland function and could help treat acne.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Carbon dots show promise for tissue repair and growth but need more research to solve current challenges.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Atorvastatin in a keratin hydrogel may help treat skin scars effectively.

New drugs for heart disease may be developed from molecules secreted by stem cells.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Baricitinib was effective in treating both early and late onset alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Many drugs can cause lipid metabolism issues, and labels need better warnings.